These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study. Merello M; Nouzeilles MI; Cammarota A; Leiguarda R Clin Neuropharmacol; 1999; 22(5):273-6. PubMed ID: 10516877 [TBL] [Abstract][Full Text] [Related]
5. Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease. Fox SH; Metman LV; Nutt JG; Brodsky M; Factor SA; Lang AE; Pope LE; Knowles N; Siffert J Mov Disord; 2017 Jun; 32(6):893-903. PubMed ID: 28370447 [TBL] [Abstract][Full Text] [Related]
6. Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease. Verhagen Metman L; Del Dotto P; van den Munckhof P; Fang J; Mouradian MM; Chase TN Neurology; 1998 May; 50(5):1323-6. PubMed ID: 9595981 [TBL] [Abstract][Full Text] [Related]
7. AFQ056 treatment of levodopa-induced dyskinesias: results of 2 randomized controlled trials. Berg D; Godau J; Trenkwalder C; Eggert K; Csoti I; Storch A; Huber H; Morelli-Canelo M; Stamelou M; Ries V; Wolz M; Schneider C; Di Paolo T; Gasparini F; Hariry S; Vandemeulebroecke M; Abi-Saab W; Cooke K; Johns D; Gomez-Mancilla B Mov Disord; 2011 Jun; 26(7):1243-50. PubMed ID: 21484867 [TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of amantadine on L-dopa-induced dyskinesias in Parkinson's disease. Luginger E; Wenning GK; Bösch S; Poewe W Mov Disord; 2000 Sep; 15(5):873-8. PubMed ID: 11009193 [TBL] [Abstract][Full Text] [Related]
9. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients. Kumar R; Hauser RA; Mostillo J; Dronamraju N; Graf A; Merschhemke M; Kenney C Int J Neurosci; 2016; 126(1):20-4. PubMed ID: 24007304 [TBL] [Abstract][Full Text] [Related]
10. The effect of amantadine on levodopa-induced dyskinesias in Parkinson's disease: a double-blind, placebo-controlled study. Snow BJ; Macdonald L; Mcauley D; Wallis W Clin Neuropharmacol; 2000; 23(2):82-5. PubMed ID: 10803797 [TBL] [Abstract][Full Text] [Related]
11. Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease. Tronci E; Fidalgo C; Zianni E; Collu M; Stancampiano R; Morelli M; Gardoni F; Carta M Neuroscience; 2014 Apr; 265():245-52. PubMed ID: 24486947 [TBL] [Abstract][Full Text] [Related]
12. NMDA antagonist memantine improves levodopa-induced dyskinesias and "on-off" phenomena in Parkinson's disease. Varanese S; Howard J; Di Rocco A Mov Disord; 2010 Mar; 25(4):508-10. PubMed ID: 20014061 [No Abstract] [Full Text] [Related]